Physiologically Based Pharmacokinetic Modeling and Simulation to Support a Change in the FDA-Labeled Dosing Frequency of RHB-105 Low-Dose Rifabutin Triple Therapy for Helicobacter pylori Eradication. - Vakil N; Howden CW; Shah SC; Chen KF; Offman E; Almenoff JS; Sheldon KL (Journal of clinical pharmacology, 2025)